Kellner Capital’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Kellner Capital’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,016	Closed	-$1.5M	–	48
2022 Q4	$1.5M	Buy	+100,016	New	+$1.38M	1.74%	16

Kellner Capital's AVEO Position: Q1 2023 in Review

Kellner Capital sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 100,016 shares — an estimated $1.5M sold.

Kellner Capital first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $1.5M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Kellner Capital reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Kellner Capital sold 100,016 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.5M.
Kellner Capital first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Kellner Capital's AVEO Pharmaceuticals, Inc. position peaked at $1.5M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Kellner Capital's 13F filing for Q1 2023, filed 9 May 2023.